化学
选择性
基质金属蛋白酶
螯合作用
锌
电位滴定法
基质金属蛋白酶抑制剂
组合化学
立体化学
体外
齿合度
羧酸盐
生物化学
金属
催化作用
有机化学
离子
作者
Elisa Nuti,Doretta Cuffaro,E. Bernardini,Caterina Camodeca,Laura Panelli,Sílvia Chaves,Lidia Ciccone,Livia Tepshi,Laura Vera,Elisabetta Orlandini,Susanna Nencetti,Enrico Adriano Stura,Maria Amélia Santos,Vincent Dive,Armando Rossello
标识
DOI:10.1021/acs.jmedchem.8b00096
摘要
Matrix metalloproteinase-12 (MMP-12) selective inhibitors could play a role in the treatment of lung inflammatory and cardiovascular diseases. In the present study, the previously reported 4-methoxybiphenylsulfonyl hydroxamate and carboxylate based inhibitors ( 1b and 2b ) were modified to enhance their selectivity for MMP-12. In the newly synthesized thioaryl derivatives, the nature of the zinc binding group (ZBG) and the sulfur oxidation state were changed. Biological assays carried out in vitro on human MMPs with the resulting compounds led to identification of a sulfide, 4a, bearing an N -1-hydroxypiperidine-2,6-dione (HPD) group as new ZBG. Compound 4a is a promising hit compound since it displayed a nanomolar affinity for MMP-12 with a marked selectivity over MMP-9, MMP-1, and MMP-14. Solution complexation studies with Zn 2+ were performed to characterize the chelating abilities of the new compounds and confirmed the bidentate binding mode of HPD derivatives. X-ray crystallography studies using MMP-12 and MMP-9 catalytic domains were carried out to rationalize the biological results.
科研通智能强力驱动
Strongly Powered by AbleSci AI